Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection

被引:50
作者
Frost, SDW
Martinez-Picado, J
Ruiz, L
Clotet, B
Brown, AJL
机构
[1] Univ Calif San Diego, Dept Pathol, Antiviral Res Ctr, San Diego, CA 92103 USA
[2] Hosp Badalona Germans Trias & Pujol, IrsiCaixa Fdn, Badalona, Spain
[3] Univ Edinburgh, Ctr HIV Res, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1128/JVI.76.3.968-979.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although antiviral agents which block human immunodeficiency virus (HIV) replication can result in long-term suppression of viral loads to undetectable levels in plasma, long-term therapy fails to eradicate virus, which generally rebounds after a single treatment interruption. Multiple structured treatment interruptions (STIs) have been suggested as a possible strategy that may boost HIV-specific immune responses and control viral replication. We analyze viral dynamics during four, consecutive STI cycles in 12 chronically infected patients with a history (>2 years) of viral suppression under highly active antiretroviral therapy. We fitted a simple model of viral rebound to the viral load data from each patient by using a novel statistical approach that allows us to overcome problems of estimating viral dynamics parameters when there are many viral load measurements below the limit of detection. There is an approximate halving of the average viral growth rate between the first and fourth STI cycles, yet the average time between treatment interruption and detection of viral loads in the plasma is approximately the same in the first and fourth interruptions. We hypothesize that reseeding of viral reservoirs during treatment interruptions can account for this discrepancy, although factors such as stochastic effects and the strength of HIV-specific immune responses may also affect the time to viral rebound. We also demonstrate spontaneous drops in viral load in later STIs, which reflect fluctuations in the rates of viral production and/or clearance that may be caused by a complex interaction between virus and target cells and/or immune responses.
引用
收藏
页码:968 / 979
页数:12
相关论文
共 52 条
  • [1] Less is more? STI in acute and chronic HIV-1 infection
    Altfeld, M
    Walker, BD
    [J]. NATURE MEDICINE, 2001, 7 (08) : 881 - 884
  • [2] Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
    Bonhoeffer, S
    Rembiszewski, M
    Ortiz, GM
    Nixon, DF
    [J]. AIDS, 2000, 14 (15) : 2313 - 2322
  • [3] Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus
    Burroughs, NJ
    Pillay, D
    Mutimer, D
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 266 (1436) : 2359 - 2366
  • [4] Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
    Chun, TW
    Davey, RT
    Ostrowski, M
    Justement, JS
    Engel, D
    Mullins, JI
    Fauci, AS
    [J]. NATURE MEDICINE, 2000, 6 (07) : 757 - 761
  • [5] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
    Chun, TW
    Stuyver, L
    Mizell, SB
    Ehler, LA
    Mican, JAM
    Baseler, M
    Lloyd, AL
    Nowak, MA
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197
  • [6] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
    Davey, RT
    Bhat, N
    Yoder, C
    Chun, TW
    Metcalf, JA
    Dewar, R
    Natarajan, V
    Lempicki, RA
    Adelsberger, JW
    Millers, KD
    Kovacs, JA
    Polis, MA
    Walker, RE
    Falloon, L
    Masur, H
    Gee, D
    Baseler, M
    Dimitrov, DS
    Fauci, AS
    Lane, HC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15109 - 15114
  • [7] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
    Deeks, SG
    Wrin, T
    Liegler, T
    Hoh, R
    Hayden, M
    Barbour, JD
    Hellmann, NS
    Petropoulos, CJ
    McCune, JM
    Hellerstein, MK
    Grant, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) : 472 - 480
  • [8] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
    Finzi, D
    Blankson, J
    Siliciano, JD
    Margolick, JB
    Chadwick, K
    Pierson, T
    Smith, K
    Lisziewicz, J
    Lori, F
    Flexner, C
    Quinn, TC
    Chaisson, RE
    Rosenberg, E
    Walker, B
    Gange, S
    Gallant, J
    Siliciano, RF
    [J]. NATURE MEDICINE, 1999, 5 (05) : 512 - 517
  • [9] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
    Finzi, D
    Hermankova, M
    Pierson, T
    Carruth, LM
    Buck, C
    Chaisson, RE
    Quinn, TC
    Chadwick, K
    Margolick, J
    Brookmeyer, R
    Gallant, J
    Markowitz, M
    Ho, DD
    Richman, DD
    Siliciano, RF
    [J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300
  • [10] FROST SDW, 2001, AIDS CYBER J, V4